Germ Cell Tumors Market

Germ Cell Tumors Market: Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Market Overview

Growth in form of tumors resulting from reproductive cells is called germ cell tumors. These can be cancerous or no n cancerous. When the germ cell tumors turn cancerous they either for testicular or ovarian cancer.

It is less likely that germ cells tumors can cause abdomen, brain and chest cancer. Germ cell tumors respond well to treatments and have great survival arte even if diagnosed at a later stage.

Germ cell tumors when found in the testes of a male in his adolescence age appear as a solid mass that is enlarged in shape than regular which may or may not be painful. When these Germ cell tumors of the ovaries, can be distinguished from cysts within the ovary, with ultrasound imaging.

Germ cell tumors may spread to other body parts like lymph nodes, liver, brain and sometimes lung. Many a times germ cell tumors resemble in secreting hormones like the ones during puberty.

Germ cell tumors are less likely seen in abnormal testes. They may be seen in abnormal ovaries or testes. These abnormalities are caused by genetic syndromes like Turners syndrome.

Germ cell tumors Market: Drivers and restraints

The main factor for the growth of germ cell tumors treatment market is the rising incidences of germ cell cancers.  Development of novel drugs and chemotherapies and many drugs into clinical trials is a driving force for the germ cell tumor market. 

The global germ cell tumors treatment market that targets mainly ovarian and testicular cancer in anticipated to grow rapidly in coming years. The survival rate for a stage III tumor patients is around 87%. The survival rate for germ cell tumor patients in stage IV of cancer is 82%.

The greater survival rates with these cancers is a convincing opportunity for market players. Increasing expenditure on oncology drugs is expected to boost the growth of the germ cell tumor market. It is reported that in 2015 around 14% of total drug expenditure in Europe was oncology drug market. Testicular cancer is in the US is common amongst white men than black men.

Prevalence of germ cell tumor is higher in developed countries than developing countries. Increasing number of female developing ovarian cancer is a driving the growth of this market.

Many big pharma companies like Pfizer have investigational drugs into clinical trial. There is large competition for chemotherapy drug for market players.

The treatment options may not be cost effective to people in developing countries.  These factors are majorly responsible for restraining the growth of the germ cell tumor market.

Germ cell tumors Market Overview:

Research in the area of germ cell tumor treatment had led better ways in the past few years. The research involves investigating high risk genes and assessment of the type of cancer developed by the germ cell.

New chemotherapy drugs are being tested. Combination therapies are also being researched by premium cancer institutes in the US and UK. Genetic therapy drugs like Cisplatin are widely used for the ovarian cancer.

Increasing interest in stem cell transplant and stem research has widened the researchers outlook for novel treatment options for testicular cancer and germ cell tumor as a whole. Advancements in surgeries like robot assisted surgeries to remove lymph nodes post chemotherapy is benefitting the patients with germ cell tumors.

Germ cell tumors Market Region wise outlook:

Collaborations of hospitals with research labs has opened new gates for research and treatment of germ cell tumor. Many institutions have invested in funding research in UK.

Funding on research includes diagnostic marker investigation, Immunotherapy, genetic testing, DNA damage and repair and resistance to certain chemotherapy drugs. National Cancer Institute in the US is conducting several clinical trials for ovarian and testicular cancer.

Germ cell tumors Market players:

The key participants operating in the germ cell tumors market are

  • Pfizer Inc
  • Merck and Co 
  • Teva Parenteral Medicines Inc
  • Mylan Laboratories ltd
  • Cipla Limited
  • Accord healthcare
  • GLS Pharma 
  • Actiza Pharmaceutical Private Limited
  • Cadila Pharmaceuticals Ltd
  • Alkem Laboratories Ltd
  • Fresenius Kabi Oncology Limited.

The research report on germ cell tumor presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report on germ cell tumor provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprints.

Germ cell tumors Market: Segmentation

The global germ cell tumors market is segmented based on the type of cancer, application, distribution channels and region.

By type of cancer

  • Testicular
  • Ovarian
  • Others

By type of drug:

  • Cisplatin
  • Etoposide
  • Bleomycin
  • Others

By route of administration:

  • Oral
  • Intravenous
  • Intraperitoneal

By distribution channel :

  • Hospital pharmacies
  • Online pharmacies
  • Specialty clinics
  • Research laboratories

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports


Germ Cell Tumors Market